Alzheimer Disease/Dementia

>

Latest News

Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data Announced
Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data

September 11th 2025

FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease
FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease

September 1st 2025

PET Imaging Validates Direct Brain Delivery of Intranasal Insulin in Alzheimer Disease: Daily Dose / image credit: ©New Africa/AdobeStock
PET Imaging Validates Direct Brain Delivery of Intranasal Insulin in Alzheimer Disease: Daily Dose

August 27th 2025

Mediterranean Diet Linked to Reduced Risk of Dementia, Especially in High-Genetic-Risk Groups / image credit  ©Yaruniv-Studio/stock.adobe.com
Mediterranean Diet Linked to Reduced Risk of Dementia, Especially in Groups With High Genetic Risk

August 25th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.